Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for oligohydramnios
IRCT20091023002624N21Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sildenafil in Oligohydramnios (Oligo), sponsored by Iran University of Medical Sciences. Started Dec 2017; status: completed.
02
Drugs
sildenafil
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on IRCT20091023002624N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091023002624N21.